A detailed history of Bbr Partners, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Bbr Partners, LLC holds 20,988 shares of NRIX stock, worth $416,192. This represents 0.04% of its overall portfolio holdings.

Number of Shares
20,988
Previous 20,988 -0.0%
Holding current value
$416,192
Previous $438,000 7.53%
% of portfolio
0.04%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$7.86 - $10.08 $164,965 - $211,559
20,988 New
20,988 $164,000
Q1 2023

May 11, 2023

BUY
$8.56 - $13.26 $179,657 - $278,300
20,988 New
20,988 $186,000

Others Institutions Holding NRIX

About Nurix Therapeutics, Inc.


  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $935M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Bbr Partners, LLC Portfolio

Follow Bbr Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bbr Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bbr Partners, LLC with notifications on news.